0000899243-20-012349.txt : 20200507 0000899243-20-012349.hdr.sgml : 20200507 20200507210059 ACCESSION NUMBER: 0000899243-20-012349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200505 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kemmerly David L CENTRAL INDEX KEY: 0001673554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 20858420 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-05 0 0000896262 AMEDISYS INC AMED 0001673554 Kemmerly David L 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 See Remarks Common Stock 2020-05-05 4 M 0 18750 27.35 A 38892 D Common Stock 2020-05-05 4 M 0 1562 27.35 A 40454 D Common Stock 2020-05-05 4 M 0 3125 27.35 A 43579 D Common Stock 2020-05-05 4 S 0 3142 174.41 D 40437 D Common Stock 2020-05-05 4 S 0 13858 175.17 D 26579 D Common Stock 2020-05-05 4 S 0 6044 176.04 D 20535 D Common Stock 2020-05-05 4 S 0 393 176.80 D 20142 D Common Stock 506 I Through 401(k) Plan Stock Option (right to buy) 27.35 2020-05-05 4 M 0 18750 0.00 D 2025-05-01 Common Stock 18750 0 D Stock Option (right to buy) 27.35 2020-05-05 4 M 0 1562 0.00 D 2025-05-01 Common Stock 1562 1563 D Stock Option (right to buy) 27.35 2020-05-05 4 M 0 3125 0.00 D 2025-05-01 Common Stock 3125 3125 D The total amount of shares beneficially owned includes 251 shares held in an employee stock purchase plan account. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.63 to $174.62, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.63 to $175.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.63 to $176.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. The information in this report is based on a plan statement dated as of March 31, 2020. On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock, subject to time-based vesting conditions. 18,750 of the options vested on May 1, 2019, and the remaining 18,750 options vested on May 1, 2020. After the transaction being reported herein, the reporting person has exercised all of these time-based options. On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 9,375 shares (the "2017 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2017 Tranche Options vested on each of May 1, 2018, May 1, 2019 and May 1, 2020. After the transaction being reported herein, 1,563 of the 2017 Tranche Options remain unexercised. On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 9,375 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019, and the remaining two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transaction being reported herein, 3,125 of the 2018 Tranche Options remain unexercised. Chief Legal and Government Affairs Officer /s/ Jennifer R. Guckert, pursuant to a power of attorney 2020-05-07